Lupin receives FDA approval for Generic Topicort LP Emollient cream and Topicort cream
Lupin has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the USFDA to market a generic equivalent of Taro Pharmaceuticals North America, Inc’s Topicort LP Emollient Cream, 0.05 percent and Taro Pharmaceuticals, Inc’s Topicort Cream, 0.25 percent.
January 11, 2017 / 02:12 PM IST
Lupin Ltd has informed BSE regarding a Press Release dated January 11, 2017 titled "Lupin Receives FDA Approval for Generic Topicort
Read More
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
